| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2013/10/12 | 05 : 46 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/12 | 05 : 37 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 19 : 00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 43 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 42 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 40 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 39 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 38 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 36 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 35 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 34 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 28 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 27 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 19 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 17 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 14 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 13 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/02 | 05 : 05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/01 | 21 : 58 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/01 | 19 : 34 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/01 | 19 : 21 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 2013/10/01 | 19 : 00 | PR Newswire (US) | Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |